We consent to the incorporation by reference in the registration statements on Form F-3 (No. 333-281750 and No. 333-275002) and registration statements on Form S-8 (No. 333-266868 and No. 333-259489) of our report dated March 23, 2026, with respect to the consolidated financial statements of Chemomab Therapeutics Ltd.